Hanis Zulkifly1, Gregory Y H Lip1,2, Deirdre A Lane1,2. 1. Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. 2. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Abstract
BACKGROUND: The most common type of arrhythmia in the USA and in European countries is atrial fibrillation (AF). The prevalence of AF is increasing worldwide with advances in technology, better prediction methods and increased awareness among healthcare professionals and patients. METHODS: This article summarises the literature on the epidemiology of AF worldwide according to continents, age and ethnicity/race, and also includes the prevalence of AF in stroke patients. RESULTS: In Australia, Europe and the USA, the current estimated prevalence of AF is about between 1% and 4%, with lower prevalence evident in Asia (0.49%-1.9%). AF prevalence is highest among Whites. In Western Europe, Australia and North America 70% of people with AF are aged >65 years, whereas the average age of AF patients in other geographical regions is often lower. CONCLUSIONS: Although the prevalence of AF worldwide is increasing steadily, large variation can be seen between studies and countries. Further epidemiological studies should be undertaken globally, especially in Asian and African countries so that a better and more accurate picture of the incidence and prevalence of AF can be captured, to enable stroke prevention strategies to be appropriately implemented to prevent or reduce the risk of stroke, the most severe consequence of AF.
BACKGROUND: The most common type of arrhythmia in the USA and in European countries is atrial fibrillation (AF). The prevalence of AF is increasing worldwide with advances in technology, better prediction methods and increased awareness among healthcare professionals and patients. METHODS: This article summarises the literature on the epidemiology of AF worldwide according to continents, age and ethnicity/race, and also includes the prevalence of AF in strokepatients. RESULTS: In Australia, Europe and the USA, the current estimated prevalence of AF is about between 1% and 4%, with lower prevalence evident in Asia (0.49%-1.9%). AF prevalence is highest among Whites. In Western Europe, Australia and North America 70% of people with AF are aged >65 years, whereas the average age of AFpatients in other geographical regions is often lower. CONCLUSIONS: Although the prevalence of AF worldwide is increasing steadily, large variation can be seen between studies and countries. Further epidemiological studies should be undertaken globally, especially in Asian and African countries so that a better and more accurate picture of the incidence and prevalence of AF can be captured, to enable stroke prevention strategies to be appropriately implemented to prevent or reduce the risk of stroke, the most severe consequence of AF.
Authors: Terri Victoria Newman; Nico Gabriel; Qinfeng Liang; Coleman Drake; Samar R El Khoudary; Chester B Good; Walid F Gellad; Inmaculada Hernandez Journal: J Manag Care Spec Pharm Date: 2022-02
Authors: Sophie Gupta; Martin Lutnik; Jan Niederdöckl; Sebastian Schnaubelt Journal: Int J Environ Res Public Health Date: 2022-04-15 Impact factor: 4.614
Authors: Alfredo Jose Pardo-Cabello; Victoria Manzano-Gamero; Juan de Dios Luna Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2021-03-05 Impact factor: 3.000